Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
labmedica.com
Immunology
Features Subscription Partner Sites Journal Info
RANDOX LABORATORIESSIEMENS HEALTHCARELEICA WETZLAR-GERMANY

Sulfenic Acid Test May Enhance Early Detection of Breast Cancer

By Labmedica International staff writers
Posted on 22 Sep 2009


A recent report described the development of an immunochemical test for sulfenic acid, an early indicator of oxidative stress, and a possible marker for the first stages of breast cancer.

Sulfenic acid is produced when hydrogen peroxide reacts with the amino acid cysteine. Proteins that have been modified by the addition of sulfenic acid are immunochemically distinct from the original. Applying this knowledge, investigators at the University of Michigan (Ann Arbor, USA) raised specific antibodies against sulfenic acid-modified proteins. The level of such proteins is an indicator of oxidative stress, a component of the "redox profile" that metabolically distinguishes normal and cancer cells.

The antibodies were labeled with a fluorescent tag that permitted detection of antibody binding by observation under a fluorescence microscope. Results obtained by using this system to determine the level of sulfenic acid modification of proteins in breast cancer cell lines were published in the September 10, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS). The results showed that the technique could be used to monitor differences in thiol redox status and revealed a diverse pattern of sulfenic acid modifications across different subtypes of breast tumors.

"For each line, we saw a very distinct pattern of sulfenic acid modifications," said senior author Dr. Kate S. Carroll, assistant professor of chemistry at the University of Michigan. "Whether the patterns we see will correlate with response to antioxidant treatment or other therapies that modulate oxidative stress level remains to be seen, but now we at least have a way to investigate that question.
Some of the modified proteins may not play any role, but I am sure it will turn out that many of them do. Once we find out which proteins are involved, we can target them directly rather than using global treatments like antioxidants. Being able to monitor a marker of oxidative stress that is associated with the activation of tumor cell growth pathways, particularly at an early stage, and then tailor treatments accordingly would allow for more targeted studies and might improve the odds of success with antioxidants and prooxidants," said Dr. Carroll.

Related Links:

University of Michigan





Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
Free digital version edition of LabMedica International sent by email on regular basis
Free print version of LabMedica International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of LabMedica International in digital format
Free LabMedica International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?




Lactate Test
Lactate Test
Hematology Controls
Hematology Controls
Steam Cleaners
Steam Cleaners

More Products

Latest Immunology News

Latest Issue
View Digital Edition
Subscribe / Renew
Alere
LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured MedBiz Market Reports
Premium Report Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Premium Report Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Featured Whitepaper
SIEMENS DIAGNOSTICS :
TRUGENE HBV Genotyping Assay

Download Whitepaper
Events
Romanian Society of Laboratory Medicine (RSML) Congress
08 Sep 2010
10 Sep 2010


17th International Meeting on Hepatitis C Virus and Related Viruses
10 Sep 2010
14 Sep 2010


Analytica China 2010
15 Sep 2010
17 Sep 2010


More events
MINDRAY-LAB
GLOBETECH PUBLISHING
CELLAVISION AB
INSTRUMENTATION LAB
FOCUS DIAGNOSTICS, INC.
AACC
THE BINDING SITE
QBC Diagnostic
  labmedica.com Copyright � 2000-2010 Globetech Media. All rights reserved.